Trade with Eva : Analytics in action: =Teva Pharma (TEVA) reported earnings on Thur 3 May 2018 (b/o)

Thursday, May 3, 2018

Teva Pharma beats by $0.27, beats on revs; raises FY18 guidance

Reports Q1 (Mar) earnings of $0.94 per share, excluding non-recurring items, $0.27 better than the Capital IQ Consensus of $0.67; revenues fell 10.0% year/year to $5.07 bln vs the $4.8 bln Capital IQ Consensus.
Co issues raised guidancefor FY18, sees EPS of $2.40-2.65 from $2.25-2.50 vs. $2.42 Capital IQ Consensus Estimate; sees FY18 revs of $18.5-19.0 bln from $18.3-18.8 bln vs. $18.62 bln Capital IQ Consensus Estimate.